• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Infections

Posted inIn the Pipeline, Infections, New Drugs, Regulatory

Shingrix: Excellent Vaccine Against Shingles

by Julia Mardi and Timur Burkhanayev April 22, 2024April 22, 2024

Shingrix for robust and long-lasting prevention of herpes zoster and postherpetic neuralgia in all adults.

Posted inInfections, New Drugs, Regulatory

mResvia, Arexvy, Abrysvo: Top Quality RSV Vaccines

by Nik Resovski and Timur Burkhanayev April 19, 2024April 19, 2024

It’s time to bury respiratory syncytial virus in the abyss of immunization fire.

bacteria
Posted inInfections, Research

Cresomycin: Breakthrough Antibiotic That Will Save Millions of Lives

by Julia Mardi, Timur Burkhanayev and Alex Avisoni April 6, 2024April 6, 2024

Cresomycin successfully combats multidrug-resistant Gram-positive and Gram-negative bacteria.

Posted inClinical Trials, COVID-19, Infections, New Drugs

Nexsheld: Updated Evusheld for Effective Vaccine-Free COVID-19 Protection

by Julia Mardi and Tanya von Reuss April 1, 2024April 1, 2024

Sipavibart injection every six months for reliable prevention of COVID-19.

Posted inCOVID-19, Infections, New Drugs, Regulatory

Pemgarda: For COVID-19 Protection Instead of Vaccines

by Tanya von Reuss April 1, 2024April 1, 2024

Pemivibart every three months. For those who cannot receive the COVID-19 vaccine.

Posted inCOVID-19, Infections, New Drugs, Regulatory

Xocova: Powerful New Japanese Pill for Coronavirus Treatment

by Nik Resovski and Timur Burkhanayev November 27, 2022December 5, 2022

Ensitrelvir by Shionogi & Co. is a highly effective antiviral drug that works just as well as Pfizer’s Paxlovid.

Posted inClinical Trials, Infections

Bepirovirsen: New Drug for Hepatitis B

by Tanya von Reuss November 11, 2022November 11, 2022

Bepirovirsen is an effective antiviral drug for the treatment of chronic hepatitis B.

Posts pagination

1 2 3 … 9 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×